| Optimization and in-vitro/in-vivo evaluation of doxorubicin-loaded chitosan-alginate nanoparticles using a melanoma mouse model K Yoncheva, M Merino, A Shenol, NT Daskalov, PS Petkov, GN Vayssilov, ... International journal of pharmaceutics 556, 1-8, 2019 | 70 | 2019 |
| Molecular dynamics-based identification of binding pathways and two distinct high-affinity sites for succinate in succinate receptor 1/GPR91 A Shenol, M Lückmann, M Trauelsen, M Lambrughi, M Tiberti, E Papaleo, ... Molecular Cell 84 (5), 955-966. e4, 2024 | 8 | 2024 |
| Optimization of first-in-class dual-acting FFAR1/FFAR4 allosteric modulators with novel mode of action M Luckmann, A Shenol, TAD Nissen, JE Petersen, D Kouvchinov, ... ACS Medicinal Chemistry Letters 13 (12), 1839-1847, 2022 | 3 | 2022 |
| Multiple recent HCAR2 structures demonstrate a highly dynamic ligand binding and G protein activation mode A Shenol, R Tenente, M Lückmann, TM Frimurer, TW Schwartz Nature Communications 15 (1), 5364, 2024 | 2 | 2024 |
| Mechanism of ligand binding pathways and activation of the succinate receptor AS Iliyaz Biophysical Journal 121 (3), 188a, 2022 | | 2022 |
| Molecular mechanism of ligand binding pathways and activation of the succinate receptor AS Iliyaz, M Luckmann, M Trauelsen, TM Frimurer, TW Schwartz EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS 50 (SUPPL 1), 160-160, 2021 | | 2021 |
| Molecular Dynamics Based Identification of Binding Pathways and Two Distinct High-Affinity Sites for Succinate in SUCNR1/GPR91 A Shenol, M Lückmann, M Trauelsen, M Lambrughi, M Tiberti, E Papaleo, ... Available at SSRN 4416988, 0 | | |